417
Participants
Start Date
November 30, 2011
Primary Completion Date
February 28, 2014
Study Completion Date
October 31, 2015
MM-398
"Arm A: MM-398 120 mg/m2 IV Q3W~Arm C: MM-398 80mg/m2 IV Q2W"
5 Fluorouracil
"Arm B: 5 Fluorouracil 2000 mg/m2 IV for 4 weeks followed by 2 weeks of rest every 6 weeks~Arm C: 5 Fluorouracil 2400 mg/m2 IV every 2 weeks"
Leucovorin
"Arm B: Leucovorin 200 mg/m2 IV for 4 weeks followed by 2 weeks of rest every 6 weeks~Arm C: Leucovorin 400 mg/m2 IV every 2 weeks"
Gilbert
Glendale
Scottsdale
Burbank
Duarte
Fresno
LaVerne
San Luis Obispo
Boyton Beach
Atlanta
Kansas City
St Louis
Henderson
Albuquerque
Buffalo
Columbus
Norman
Greenville
Bedford
Dallas
Tyler
Fairfax
Norfolk
Buenos Aires
Rosario
Santa Fe
Westmead
Kurralta Park
Boxhill
Heidelberg
Melbourne
Nedlands
Belo Horizonte
Ijuí
Passo Fundo
Porto Alegre
São Paulo
Montreal
Hořovice
Olomouc
Prague
Příbram
Bordeaux
Lille
Marseille
Berlin
Jens
Munich
Ulm
Budapest
Pécs
Szeged
Szolnok
Szombathely
Castellana Grotte
Genova
Legnano
Naples
Roma
Port Elizabeth
Pretoria
Western Cape
Hwasun-gun
Seoul
Alicante
Barcelona
Madrid
Santander
Valencia
Chiayi City
Kaohsiung City
Taiching
Tainan City
Taipei
Taoyuan District
Liverpool
London
Manchester
Sutton
Lead Sponsor
Merrimack Pharmaceuticals
INDUSTRY